219 related articles for article (PubMed ID: 28720707)
21. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity.
Ben-Saadon R; Zaaroor D; Ziv T; Ciechanover A
Mol Cell; 2006 Dec; 24(5):701-711. PubMed ID: 17157253
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of mammalian Polycomb-group proteins, Ring1B and Rae28/Ph1, from the chromatin correlates with configuration changes of the chromatin in mitotic and meiotic prophase.
Miyagishima H; Isono K; Fujimura Y; Iyo M; Takihara Y; Masumoto H; Vidal M; Koseki H
Histochem Cell Biol; 2003 Aug; 120(2):111-9. PubMed ID: 12883906
[TBL] [Abstract][Full Text] [Related]
23. Role of polycomb proteins Ring1A and Ring1B in the epigenetic regulation of gene expression.
Vidal M
Int J Dev Biol; 2009; 53(2-3):355-70. PubMed ID: 19412891
[TBL] [Abstract][Full Text] [Related]
24. RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1.
García E; Marcos-Gutiérrez C; del Mar Lorente M; Moreno JC; Vidal M
EMBO J; 1999 Jun; 18(12):3404-18. PubMed ID: 10369680
[TBL] [Abstract][Full Text] [Related]
25. Ring1B is crucial for the regulation of developmental control genes and PRC1 proteins but not X inactivation in embryonic cells.
Leeb M; Wutz A
J Cell Biol; 2007 Jul; 178(2):219-29. PubMed ID: 17620408
[TBL] [Abstract][Full Text] [Related]
26. Nupr1: the Swiss-knife of cancer.
Cano CE; Hamidi T; Sandi MJ; Iovanna JL
J Cell Physiol; 2011 Jun; 226(6):1439-43. PubMed ID: 20658514
[TBL] [Abstract][Full Text] [Related]
27. The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells.
Araujo-Abad S; Fuentes-Baile M; Rizzuti B; Bazán JF; Villamarin-Ortiz A; Saceda M; Fernández E; Vidal M; Abian O; Velazquez-Campoy A; de Juan Romero C; Neira JL
Int J Biol Macromol; 2023 Aug; 246():125632. PubMed ID: 37399862
[TBL] [Abstract][Full Text] [Related]
28. The Polycomb group protein Ring1b is essential for pectoral fin development.
van der Velden YU; Wang L; van Lohuizen M; Haramis AP
Development; 2012 Jun; 139(12):2210-20. PubMed ID: 22619390
[TBL] [Abstract][Full Text] [Related]
29. Nuclear protein 1 imparts oncogenic potential and chemotherapeutic resistance in cancer.
Murphy A; Costa M
Cancer Lett; 2020 Dec; 494():132-141. PubMed ID: 32835767
[TBL] [Abstract][Full Text] [Related]
30. RING1B ubiquitination and stability are regulated by ARF.
de Bie P; Ciechanover A
Biochem Biophys Res Commun; 2012 Sep; 426(1):49-53. PubMed ID: 22910419
[TBL] [Abstract][Full Text] [Related]
31. Conformational propensities of intrinsically disordered proteins influence the mechanism of binding and folding.
Arai M; Sugase K; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9614-9. PubMed ID: 26195786
[TBL] [Abstract][Full Text] [Related]
32. Designing and repurposing drugs to target intrinsically disordered proteins for cancer treatment: using NUPR1 as a paradigm.
Santofimia-Castaño P; Rizzuti B; Xia Y; Abian O; Peng L; Velázquez-Campoy A; Iovanna JL; Neira JL
Mol Cell Oncol; 2019; 6(5):e1612678. PubMed ID: 31528692
[TBL] [Abstract][Full Text] [Related]
33. RYBP modulates stability and function of Ring1B through targeting UBE3A.
Li M; Zhang S; Zhao W; Hou C; Ma X; Li X; Huang B; Chen H; Chen D
FASEB J; 2019 Jan; 33(1):683-695. PubMed ID: 30040487
[TBL] [Abstract][Full Text] [Related]
34. Polycomb RING1A- and RING1B-dependent histone H2A monoubiquitylation at pericentromeric regions promotes S-phase progression.
Bravo M; Nicolini F; Starowicz K; Barroso S; Calés C; Aguilera A; Vidal M
J Cell Sci; 2015 Oct; 128(19):3660-71. PubMed ID: 26272920
[TBL] [Abstract][Full Text] [Related]
35. Ring1A is a transcriptional repressor that interacts with the Polycomb-M33 protein and is expressed at rhombomere boundaries in the mouse hindbrain.
Schoorlemmer J; Marcos-Gutiérrez C; Were F; Martínez R; García E; Satijn DP; Otte AP; Vidal M
EMBO J; 1997 Oct; 16(19):5930-42. PubMed ID: 9312051
[TBL] [Abstract][Full Text] [Related]
36. NUPR1: A Critical Regulator of the Antioxidant System.
Huang C; Santofimia-Castaño P; Iovanna J
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359572
[TBL] [Abstract][Full Text] [Related]
37. Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis.
Santofimia-Castaño P; Xia Y; Lan W; Zhou Z; Huang C; Peng L; Soubeyran P; Velázquez-Campoy A; Abián O; Rizzuti B; Neira JL; Iovanna J
J Clin Invest; 2019 Mar; 129(6):2500-2513. PubMed ID: 30920390
[TBL] [Abstract][Full Text] [Related]
38. Production of monoclonal antibodies against mammalian Ring1B proteins.
Atsuta T; Fujimura S; Moriya H; Vidal M; Akasaka T; Koseki H
Hybridoma; 2001 Feb; 20(1):43-6. PubMed ID: 11289226
[TBL] [Abstract][Full Text] [Related]
39. RING1B O-GlcNAcylation regulates gene targeting of polycomb repressive complex 1 in human embryonic stem cells.
Maury JJ; El Farran CA; Ng D; Loh YH; Bi X; Bardor M; Choo AB
Stem Cell Res; 2015 Jul; 15(1):182-9. PubMed ID: 26100231
[TBL] [Abstract][Full Text] [Related]
40. Ring1B contains a ubiquitin-like docking module for interaction with Cbx proteins.
Bezsonova I; Walker JR; Bacik JP; Duan S; Dhe-Paganon S; Arrowsmith CH
Biochemistry; 2009 Nov; 48(44):10542-8. PubMed ID: 19791798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
